PMC6233704_01
Case 1: The right eye was treated. Before treatment, upper eyelid swelling, scleral show and a lack of an upper eyelid sulcus were evident in the right eye. Upper eyelid sulcus (arrow) slightly appeared 1 month after the injection. At 6 months, the scleral show and eyelid bulge resolved. At 12 months, no features of upper eyelid retraction and swelling were observed. Subcutaneous white particles of TA (arrowhead) were observed at 1 and 6 months. These were not detectable right after injection. The particles were not visible at 12 months. Case 2: The left eye was treated. Before treatment, scleral show, upper eyelid swelling and lack of an upper eyelid sulcus were evident in the left eye. At 1 month after treatment, a slight upper eyelid sulcus (arrow) could be detected. At 6 months, the scleral show and palpebral fissure height reduced. At 12 months, the scleral show resolved. Case 3: Both eyes were treated. Before treatment, scleral show, bulging eyelids and lack of an upper eyelid sulcus were evident in both eyes. At 1 month after treatment, the eyelid bulge reduced. At 6 months, the scleral show resolved and the palpebral fissure height reduced. At 12 months, the eyelid bulge resolved, although the upper eyelid sulcus was still not observable.. Abbreviation: TA, triamcinolone acetonide.
imcrj-11-325Fig2.jpg
PMC6233704_03_imcrj-11-325Fig2.jpg
f2-imcrj-11-325
Scleral show, eyelid bulging and lack of an upper eyelid sulcus were noted bilaterally (Figure 2). An upper eyelid sulcus, however, was still not observable in either eye (Figure 2).
Case 1: Pretreatment: The top left image shows T1-weighted MRI sagittal sections. Enlargement of the LPS muscle (arrow) and swelling of eyelid fat (arrowhead) are observable in the right eye, but not in the left eye (top right). Bottom image shows high-intensity signal in the LPS muscle (arrow) on a T2-weighted fat-suppressed image. Eight months posttreatment: Top left image shows that enlargement of the LPS muscle (arrow) was reduced and swelling of fat tissue (arrowhead) was not apparent. Bottom image shows that high-intensity signal in the LPS muscle (arrow) disappeared. Case 2: Pretreatment: Top right image shows mild enlargement of the LPS muscle (arrow) and mild swelling of eyelid fat (arrowhead) in the left eye. Bottom images show high-intensity signal in the LPS muscle (arrow) on a T2-weighted fat-suppressed image. Eight months posttreatment: Top right image shows that the LPS muscle (arrow) enlargement tended to improve slightly and fat tissue (arrowhead) swelling was not observable. Bottom image shows that high-intensity signal in the LPS muscle (arrow) disappeared. Case 3: Pretreatment: Top image shows enlargement of the LPS muscle (arrow) and swelling of fat tissue (arrowhead) in both eyes. Bottom shows high-intensity signals in the LPS muscle (arrow) on T2-weighted fat-suppressed image. Six months posttreatment: Top image shows improvement of enlargement of the LPS muscle (arrow) and swelling of fat tissue (arrowhead). Bottom image shows that high-intensity signals in the LPS muscle (arrow) disappeared on a T2-weighted fat-suppressed image.. Abbreviation: LPS, levator palpebrae superioris.
imcrj-11-325Fig3.jpg
PMC6233704_03_imcrj-11-325Fig3.jpg
f3-imcrj-11-325
PMC6233704_02
Case 1: The right eye was treated. Before treatment, upper eyelid swelling, scleral show and a lack of an upper eyelid sulcus were evident in the right eye. Upper eyelid sulcus (arrow) slightly appeared 1 month after the injection. At 6 months, the scleral show and eyelid bulge resolved. At 12 months, no features of upper eyelid retraction and swelling were observed. Subcutaneous white particles of TA (arrowhead) were observed at 1 and 6 months. These were not detectable right after injection. The particles were not visible at 12 months. Case 2: The left eye was treated. Before treatment, scleral show, upper eyelid swelling and lack of an upper eyelid sulcus were evident in the left eye. At 1 month after treatment, a slight upper eyelid sulcus (arrow) could be detected. At 6 months, the scleral show and palpebral fissure height reduced. At 12 months, the scleral show resolved. Case 3: Both eyes were treated. Before treatment, scleral show, bulging eyelids and lack of an upper eyelid sulcus were evident in both eyes. At 1 month after treatment, the eyelid bulge reduced. At 6 months, the scleral show resolved and the palpebral fissure height reduced. At 12 months, the eyelid bulge resolved, although the upper eyelid sulcus was still not observable.. Abbreviation: TA, triamcinolone acetonide.
imcrj-11-325Fig2.jpg
PMC6233704_03_imcrj-11-325Fig2.jpg
f2-imcrj-11-325
Scleral show, eyelid bulging and lack of an upper eyelid sulcus were noted bilaterally (Figure 2). An upper eyelid sulcus, however, was still not observable in either eye (Figure 2).
Case 1: Pretreatment: The top left image shows T1-weighted MRI sagittal sections. Enlargement of the LPS muscle (arrow) and swelling of eyelid fat (arrowhead) are observable in the right eye, but not in the left eye (top right). Bottom image shows high-intensity signal in the LPS muscle (arrow) on a T2-weighted fat-suppressed image. Eight months posttreatment: Top left image shows that enlargement of the LPS muscle (arrow) was reduced and swelling of fat tissue (arrowhead) was not apparent. Bottom image shows that high-intensity signal in the LPS muscle (arrow) disappeared. Case 2: Pretreatment: Top right image shows mild enlargement of the LPS muscle (arrow) and mild swelling of eyelid fat (arrowhead) in the left eye. Bottom images show high-intensity signal in the LPS muscle (arrow) on a T2-weighted fat-suppressed image. Eight months posttreatment: Top right image shows that the LPS muscle (arrow) enlargement tended to improve slightly and fat tissue (arrowhead) swelling was not observable. Bottom image shows that high-intensity signal in the LPS muscle (arrow) disappeared. Case 3: Pretreatment: Top image shows enlargement of the LPS muscle (arrow) and swelling of fat tissue (arrowhead) in both eyes. Bottom shows high-intensity signals in the LPS muscle (arrow) on T2-weighted fat-suppressed image. Six months posttreatment: Top image shows improvement of enlargement of the LPS muscle (arrow) and swelling of fat tissue (arrowhead). Bottom image shows that high-intensity signals in the LPS muscle (arrow) disappeared on a T2-weighted fat-suppressed image.. Abbreviation: LPS, levator palpebrae superioris.
imcrj-11-325Fig3.jpg
PMC6233704_03_imcrj-11-325Fig3.jpg
f3-imcrj-11-325
PMC6233704_03
Case 1: The right eye was treated. Before treatment, upper eyelid swelling, scleral show and a lack of an upper eyelid sulcus were evident in the right eye. Upper eyelid sulcus (arrow) slightly appeared 1 month after the injection. At 6 months, the scleral show and eyelid bulge resolved. At 12 months, no features of upper eyelid retraction and swelling were observed. Subcutaneous white particles of TA (arrowhead) were observed at 1 and 6 months. These were not detectable right after injection. The particles were not visible at 12 months. Case 2: The left eye was treated. Before treatment, scleral show, upper eyelid swelling and lack of an upper eyelid sulcus were evident in the left eye. At 1 month after treatment, a slight upper eyelid sulcus (arrow) could be detected. At 6 months, the scleral show and palpebral fissure height reduced. At 12 months, the scleral show resolved. Case 3: Both eyes were treated. Before treatment, scleral show, bulging eyelids and lack of an upper eyelid sulcus were evident in both eyes. At 1 month after treatment, the eyelid bulge reduced. At 6 months, the scleral show resolved and the palpebral fissure height reduced. At 12 months, the eyelid bulge resolved, although the upper eyelid sulcus was still not observable.. Abbreviation: TA, triamcinolone acetonide.
imcrj-11-325Fig2.jpg
PMC6233704_03_imcrj-11-325Fig2.jpg
f2-imcrj-11-325
Scleral show, eyelid bulging and lack of an upper eyelid sulcus were noted bilaterally (Figure 2). An upper eyelid sulcus, however, was still not observable in either eye (Figure 2).
Case 1: Pretreatment: The top left image shows T1-weighted MRI sagittal sections. Enlargement of the LPS muscle (arrow) and swelling of eyelid fat (arrowhead) are observable in the right eye, but not in the left eye (top right). Bottom image shows high-intensity signal in the LPS muscle (arrow) on a T2-weighted fat-suppressed image. Eight months posttreatment: Top left image shows that enlargement of the LPS muscle (arrow) was reduced and swelling of fat tissue (arrowhead) was not apparent. Bottom image shows that high-intensity signal in the LPS muscle (arrow) disappeared. Case 2: Pretreatment: Top right image shows mild enlargement of the LPS muscle (arrow) and mild swelling of eyelid fat (arrowhead) in the left eye. Bottom images show high-intensity signal in the LPS muscle (arrow) on a T2-weighted fat-suppressed image. Eight months posttreatment: Top right image shows that the LPS muscle (arrow) enlargement tended to improve slightly and fat tissue (arrowhead) swelling was not observable. Bottom image shows that high-intensity signal in the LPS muscle (arrow) disappeared. Case 3: Pretreatment: Top image shows enlargement of the LPS muscle (arrow) and swelling of fat tissue (arrowhead) in both eyes. Bottom shows high-intensity signals in the LPS muscle (arrow) on T2-weighted fat-suppressed image. Six months posttreatment: Top image shows improvement of enlargement of the LPS muscle (arrow) and swelling of fat tissue (arrowhead). Bottom image shows that high-intensity signals in the LPS muscle (arrow) disappeared on a T2-weighted fat-suppressed image.. Abbreviation: LPS, levator palpebrae superioris.
imcrj-11-325Fig3.jpg
PMC6233704_03_imcrj-11-325Fig3.jpg
f3-imcrj-11-325